American National Bank & Trust (Virginia)’s Elevance Health ELV Stock Holding History

American National Bank & Trust (Virginia)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$4.64M	Buy	+8,942	New	+$4.45M	1.1%	37

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American National Bank & Trust (Virginia)'s ELV Position: Q1 2024 in Review

American National Bank & Trust (Virginia) opened a new position in Elevance Health (ELV) in Q1 2024: 8,942 shares worth $4.64M. The stake represents 1.1% of the portfolio and ranks #37 among its holdings.

1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

American National Bank & Trust (Virginia) held 8,942 shares of Elevance Health worth $4.64M as of Q1 2024.
Elevance Health was a new American National Bank & Trust (Virginia) position in Q1 2024.
Elevance Health made up 1.1% of American National Bank & Trust (Virginia)'s portfolio in Q1 2024, its #37 holding.
1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on American National Bank & Trust (Virginia)'s 13F filing for Q1 2024, filed 19 Apr 2024.